INCREASED THROMBOXANE-MEDIATED CONTRACTIONS OF RETINAL-VESSELS OF NEWBORN PIGS TO PEROXIDES

被引:27
作者
ABRAN, D
VARMA, DR
CHEMTOB, S
机构
[1] HOP ST JUSTINE, RES CTR, DEPT PEDIAT, MONTREAL, PQ H3T 1C5, CANADA
[2] HOP ST JUSTINE, DEPT PHARMACOL, MONTREAL, PQ H3T 1C5, CANADA
[3] MCGILL UNIV, DEPT PHARMACOL & THERAPEUT, MONTREAL, PQ H3G 1Y6, CANADA
来源
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY | 1995年 / 268卷 / 02期
关键词
RETINAL VASCULAR RESPONSES; PEROXIDE VASOACTIVITY;
D O I
10.1152/ajpheart.1995.268.2.H628
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The vasomotor effects of three peroxides (H2O2, cumene hydroperoxide, and t-butyl hydroperoxide) on the retinal vasculature, as well as the role of thromboxane in these effects, were studied using time-frame photography of isolated eyecup preparations from newborn and adult pigs. AU three peroxides caused constriction of retinal arteries and veins, and these effects were greater in the newborn than in the adult. The cyclooxygenase inhibitor indomethacin, the thromboxane synthase blocker CGS-13080, and the thromboxane receptor blockers GR-32191B and L-670,596 inhibited the peroxide-induced vasoconstriction. The peroxides also increased thromboxane levels in the retina, and this increase was greater in newborn than in adult tissues. Both indomethacin and CGS-13080 prevented the peroxide-induced increase in retinal thromboxane. The thromboxane analogue U-46619 also produced constriction of newborn and adult retinal vessels, but its effects on the retinal veins of newborn pigs were less than those on adult veins. Data indicate an important role for increased production of thromboxane in the relative increase in the vasoconstrictor effects of peroxides on the newborn retinal vasculature. These findings suggest that the vasoconstriction and occlusion after oxidative stresses, which precede retinal neovascularization, are mediated by thromboxane.
引用
收藏
页码:H628 / H632
页数:5
相关论文
共 31 条
  • [11] THE PHARMACOLOGY OF L-670,596, A POTENT AND SELECTIVE THROMBOXANE PROSTAGLANDIN ENDOPEROXIDE RECEPTOR ANTAGONIST
    FORDHUTCHINSON, AW
    GIRARD, Y
    LORD, A
    JONES, TR
    CIRINO, M
    EVANS, JF
    GILLARD, J
    HAMEL, P
    LEVEILLE, C
    MASSON, P
    YOUNG, R
    [J]. CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 1989, 67 (09) : 989 - 993
  • [12] HARDY P, 1994, INVEST OPHTH VIS SCI, V35, P580
  • [13] LIPID HYDROPEROXIDES POTENTIATE MESENTERIC-ARTERY VASOCONSTRICTOR RESPONSES
    HUBEL, CA
    DAVIDGE, ST
    MCLAUGHLIN, MK
    [J]. FREE RADICAL BIOLOGY AND MEDICINE, 1993, 14 (04) : 397 - 407
  • [14] ANGIOGENESIS IN SKELETAL AND CARDIAC-MUSCLE
    HUDLICKA, O
    BROWN, M
    EGGINTON, S
    [J]. PHYSIOLOGICAL REVIEWS, 1992, 72 (02) : 369 - 417
  • [15] EICOSANOIDS IN 3RD VENTRICULAR CEREBROSPINAL-FLUID OF FETAL AND NEWBORN SHEEP
    JONES, SA
    ADAMSON, SL
    BISHAI, I
    LEES, J
    ENGELBERTS, D
    COCEANI, F
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY, 1993, 264 (01): : R135 - R142
  • [16] KOIDE T, 1982, J PHARMACOL EXP THER, V221, P481
  • [17] GR32191, A HIGHLY POTENT AND SPECIFIC THROMBOXANE A2 RECEPTOR BLOCKING DRUG ON PLATELETS AND VASCULAR AND AIRWAYS SMOOTH-MUSCLE INVITRO
    LUMLEY, P
    WHITE, BP
    HUMPHREY, PPA
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 1989, 97 (03) : 783 - 794
  • [18] MOORE SA, 1988, AM J PHYSIOL, V254, pC37
  • [19] OLIVER PD, 1992, INVEST OPHTH VIS SCI, V33, P1909
  • [20] PENN JS, 1992, INVEST OPHTH VIS SCI, V33, P1836